If there existed a meaningful product upon which to build a consensus price based upon sales, your question would be a little easier to address. At this point, it is personal...what do you think that someone else will be willing to pay for dreams? Companies tend not to base aquisitions on future sales unless there is a product to sell. There is just not a big enough market for Cetrotide upon which to assign a value to the stock. So at this point in time, minus the MM trial, they is nothing to buy.